Sign in
4

Changes in Ownership

Vera Therapeutics, Inc. Filed Acc 0001209191-22-011224

Options or other derivatives

  • Chief Development Officer acquired 52,964 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Curley Joanne Chief Development Officer 2022-02-16 Grant or award · Stock Option (right to buy) +52,964 52,964 D: show line 1 in the form
Loading xslF345X03/doc4.xml…